Filing Flows › CVS Health (CVS) › Q2 2026 › vs Q1 2026
CVS Health (CVS) Q2 2026 vs Q1 2026 (quarter over quarter)
CVS Health's revenue rose $5.7B (+6%) from $100.4B in Q1 2026 to $106.1B in Q2 2026. Operating margin 4.4% against 4.7% (-0.2 pts).
CVS Health, Q2 2026: revenue $106.1B (+7% year over year), operating margin 4.4%, net earnings $3.0B, operating cash flow $6.3B. The chart draws each line against Q1 2026, the increases inside each band.
Margins
| Q2 2026 | Q1 2026 | Change | |
|---|---|---|---|
| Operating margin | 4.4% | 4.7% | -0.2 pts |
| Net margin | 2.8% | 2.9% | -0.1 pts |
| Free cash flow margin | 5.3% | 3.4% | +1.9 pts |
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $106.1B | $100.4B | $5.7B | +6% |
| Operating profit | $4.7B | $4.7B | $23.0M | +0.5% |
| Costs & expenses | $101.4B | $95.7B | $5.6B | +6% |
| Pre-tax earnings | $4.0B | $3.9B | $39.0M | +1% |
| Other expense, net | $726M | $742M | −$16.0M | -2% |
| Cost of revenue | $58.9B | $55.4B | $3.4B | +6% |
| Other operating costs | $42.5B | $40.3B | $2.2B | +6% |
| Net earnings | $3.0B | $3.0B | $38.0M | +1% |
| Income tax | $982M | $981M | $1.0M | +0.1% |
| Depreciation & amortization | $1.1B | $1.1B | $11.0M | +1% |
| Share-based compensation | $176M | $266M | −$90.0M | -34% |
| Working capital & other | $2.0B | −$89.0M | $2.1B | — |
| Operating cash flow | $6.3B | $4.2B | $2.1B | +49% |
| Free cash flow (OCF − capex) | $5.7B | $3.4B | $2.3B | +66% |
| Capital expenditures | $691M | $849M | −$158M | -19% |
Questions
How much did CVS Health's revenue grow quarter over quarter in Q2 2026?
CVS Health's revenue rose $5.7B (+6%) from $100.4B in Q1 2026 to $106.1B in Q2 2026. Operating margin 4.4% against 4.7% (-0.2 pts).